Rapamycin induces a persistent epigenetic memory of youth that outlasts drug exposure

Hypothesis

Rapamycin’s inhibition of mTORC1 triggers autophagy and downstream FOXO/ATF4 signaling, which are classically viewed as a hormetic stress response that mimics caloric restriction Rapamycin extends lifespan primarily by slowing damage accumulation Both rapamycin and CR inhibit mTORC1, but their effects are age-, tissue-, and time-of-day dependent. It's plausible that the epigenetic mark recruits co‑activators that maintain FOXO transcription. Yet persistent benefits after drug withdrawal suggest that the pathway may also write a lasting epigenetic program that sustains a youthful transcriptional state. We hypothesize that rapamycin induces a stable chromatin configuration at loci governing proteostasis and mitochondrial function, converting a transient stress signal into a durable repair program. This epigenetic memory would be detectable as sustained histone acetylation and reduced DNA methylation at FOXO‑target promoters long after the drug is cleared, and it would correlate with continued improvement in tissue function even when mTOR activity returns to baseline.

Predictions

• Histone H3K27ac levels at FOXO‑dependent enhancers remain elevated for at least four weeks after rapamycin cessation in mouse liver and heart.
• DNA methylation at CpG islands of FOXO3 and SIRT1 promoters shows a significant decrease that persists post‑treatment, whereas global methylation patterns revert to pretreatment levels.
• Animals treated with rapamycin for a short window (2 weeks) exhibit improved mitochondrial respiration and reduced protein carbonylation eight weeks after drug washout, despite mTORC1 activity returning to baseline.
• Pharmacological blockade of histone acetyltransferases (e.g., with C646) during rapamycin exposure abolishes the long‑term functional improvements, indicating that the acetylation mark is required for the persistent effect.

Experimental Design

1. Treatment cohorts – Young adult mice receive either rapamycin (14 mg/kg diet) for two weeks, vehicle, or rapamycin plus a HAT inhibitor. A fourth group receives rapamycin for two weeks followed by a washout period.
2. Sampling schedule – Tissue (liver, heart, skeletal muscle) is collected at 0 h, 24 h, 1 week, 2 weeks (end of treatment), and 4 weeks, 8 weeks post‑washout.
3. Assays – ChIP‑seq for H3K27ac and FOXO3 Hormetic stress pathways can be triggered by various stimuli and may produce molecular signatures that mimic rejuvenation without necessarily reversing underlying damage, whole‑genome bisulfite sequencing for DNA methylation, RNA‑seq for transcriptional profiling, Seahorse analysis for mitochondrial respiration, and protein carbonylation ELISA.
4. Readouts – Compare epigenetic marks and functional endpoints between rapamycin‑only and rapamycin + HAT‑inhibitor groups. Persistent changes in the rapamycin‑only group that are lost in the inhibitor condition would support the hypothesis.
5. Statistical plan – Two‑way ANOVA with factors treatment and time, followed by Tukey’s post‑hoc test; significance set at p < 0.05.

If the data show that specific histone acetylation and hypomethylation at FOXO‑target loci endure after rapamycin clearance and are necessary for sustained physiological benefits, the hypothesis would be validated, indicating that rapamycin can enact a bona fide repair program rather than merely impersonating a harder life short-term rapamycin treatment was shown to regenerate periodontal bone and revert the oral microbiome to a more youthful state in aged mice improved cardiac function in mice persists for at least 8 weeks after treatment cessation.